Covered recipient · General Payments record
MITCHEL P GOLDMAN
Allopathic & Osteopathic Physicians Dermatology Procedural Dermatology
General Payments · PY2018–2024
$437,272.48
- Reported across 325 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $4,265.42 | 4 |
| Food and Beverage | $856.35 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $2,148.75 | 2 |
| Biofrontera Inc. | $1,594.08 | 5 |
| ABBVIE INC. | $978.33 | 22 |
| REVANCE THERAPEUTICS, INC. | $103.82 | 3 |
| Solta Medical, a division of Bausch Health US, LLC | $103.68 | 1 |
| Regeneron Pharmaceuticals, Inc. | $99.30 | 1 |
| Incyte Corporation | $57.02 | 1 |
| Galderma Laboratories, L.P. | $36.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.00 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811798 | CMS |
| ABBVIE INC. | $17.21 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811800 | CMS |
| ABBVIE INC. | $1.89 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811802 | CMS |
| ABBVIE INC. | $16.85 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811804 | CMS |
| ABBVIE INC. | $15.09 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811806 | CMS |
| ABBVIE INC. | $3.34 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811808 | CMS |
| ABBVIE INC. | $6.75 | 03/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811810 | CMS |
| ABBVIE INC. | $27.31 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811812 | CMS |
| ABBVIE INC. | $33.78 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811814 | CMS |
| ABBVIE INC. | $20.54 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811816 | CMS |
| ABBVIE INC. | $29.47 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811818 | CMS |
| ABBVIE INC. | $24.59 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811820 | CMS |
| ABBVIE INC. | $616.67 | 07/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103134827 | CMS |
| ABBVIE INC. | $29.27 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811822 | CMS |
| ABBVIE INC. | $13.28 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811824 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811826 | CMS |
| ABBVIE INC. | $12.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811828 | CMS |
| ABBVIE INC. | $29.47 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811830 | CMS |
| ABBVIE INC. | $19.84 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811832 | CMS |
| ABBVIE INC. | $22.66 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811834 | CMS |
| ABBVIE INC. | $9.33 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811836 | CMS |
| ABBVIE INC. | $12.41 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103811838 | CMS |
| Biofrontera Inc. | $70.34 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091175095 | CMS |
| Biofrontera Inc. | $10.17 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093026191 | CMS |
| Biofrontera Inc. | $1,500.00 | 03/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142415631 | CMS |
| Biofrontera Inc. | $12.95 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110849134 | CMS |
| Biofrontera Inc. | $0.62 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111023865 | CMS |
| Galderma Laboratories, L.P. | $36.79 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145300148 | CMS |
| Incyte Corporation | $57.02 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141171389 | CMS |
| Regeneron Healthcare Solutions, Inc. | $238.75 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114057292 | CMS |
| Regeneron Healthcare Solutions, Inc. | $1,910.00 | 09/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1114057294 | CMS |
| Regeneron Pharmaceuticals, Inc. | $99.30 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114399363 | CMS |
| REVANCE THERAPEUTICS, INC. | $33.17 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918912 | CMS |
| REVANCE THERAPEUTICS, INC. | $36.74 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918914 | CMS |
| REVANCE THERAPEUTICS, INC. | $33.91 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918916 | CMS |
| Solta Medical, a division of Bausch Health US, LLC | $103.68 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143957988 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.